{
    "code": "01041440",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01041440",
    "time": "2022-08-05 12:08:39",
    "許可證字號": "衛署藥製字第041440號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/06\/28",
    "發證日期": "86\/06\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104144007",
    "中文品名": "&quot; 衛達 &quot;幾丁原膠囊250毫克（硫酸固可沙明）",
    "英文品名": "CHITOGEN CAPSULES 250MG &quot;WEIDAR&quot;(GLUCOSAMINE SULFATE)",
    "適應症": "緩解退化性關節炎之疼痛。",
    "劑型": "130膠囊劑",
    "包裝": "8-1000粒塑膠瓶裝 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GLUCOSAMINE SULFATE CRYSTALLINE",
    "限制項目": "01國　產",
    "申請商名稱": "1605609200  衛達化學製藥股份有限公司",
    "申請商地址": "台中市工業區２３路２１號",
    "主製造廠": [
        {
            "製造廠名稱": "1605609300  衛達化學製藥股份有限公司",
            "製造廠廠址": "台中市工業區２３路２１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9600013400",
            "成分名稱": "GLUCOSAMINE SULFATE CRYSTALLINE",
            "含量描述": "(eq to glucosamine sulfate 250mg)",
            "含量": "314.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "#1 膠囊 (頭：不透明紅色\/身：米白色)",
        "特殊劑型": "",
        "顏色": "不透明紅色\/米白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "頭：WEIDAR",
        "標記二": "身：CT0921"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "4.0_Chitogen Cap. 250mg_劑型外觀-104-10-19(廠商自行上傳).PDF",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=364&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "041440Chitogen Capsules 250mg_OTC標準化仿單-1080814-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=007&Type=9"
        },
        {
            "title": "Chitogen Capsules 250mg_OTC標準化外盒-1080805-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=011&Type=8"
        },
        {
            "title": "Chitogen Capsules 250mg_OTC標準化標籤_1080805-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=010&Type=8"
        },
        {
            "title": "Chitogen Capsules 250mg_QR CODE資訊_1080802-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=009&Type=8"
        },
        {
            "title": "Chitogen Capsules 250mg_鋁箔-108-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01041440&Seq=008&Type=8"
        }
    ]
}